Principal Financial Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,372
Closed -$30.1K 2259
2024
Q2
$30.1K Sell
17,372
-7,093
-29% -$12.3K ﹤0.01% 2320
2024
Q1
$58.5K Sell
24,465
-93
-0.4% -$222 ﹤0.01% 2332
2023
Q4
$81.8K Buy
24,558
+176
+0.7% +$586 ﹤0.01% 2291
2023
Q3
$91.2K Sell
24,382
-369,858
-94% -$1.38M ﹤0.01% 2296
2023
Q2
$1.68M Sell
394,240
-8,212
-2% -$35.1K ﹤0.01% 1782
2023
Q1
$2.75M Sell
402,452
-9,135
-2% -$62.5K ﹤0.01% 1706
2022
Q4
$3.26M Sell
411,587
-19,686
-5% -$156K ﹤0.01% 1666
2022
Q3
$4.15M Sell
431,273
-39,532
-8% -$380K ﹤0.01% 1556
2022
Q2
$3.41M Sell
470,805
-20,141
-4% -$146K ﹤0.01% 1681
2022
Q1
$6.34M Sell
490,946
-28,666
-6% -$370K ﹤0.01% 1575
2021
Q4
$8.29M Sell
519,612
-123,670
-19% -$1.97M 0.01% 1490
2021
Q3
$10.3M Sell
643,282
-17,636
-3% -$283K 0.01% 1385
2021
Q2
$9.14M Buy
660,918
+103,886
+19% +$1.44M 0.01% 1472
2021
Q1
$8.14M Buy
557,032
+10,018
+2% +$146K 0.01% 1482
2020
Q4
$9.51M Sell
547,014
-34,204
-6% -$594K 0.01% 1261
2020
Q3
$10.7M Buy
581,218
+48,953
+9% +$898K 0.01% 1034
2020
Q2
$9.51M Buy
532,265
+485,108
+1,029% +$8.66M 0.01% 1087
2020
Q1
$765K Buy
47,157
+629
+1% +$10.2K ﹤0.01% 1783
2019
Q4
$838K Buy
46,528
+35,710
+330% +$643K ﹤0.01% 1859
2019
Q3
$219K Buy
10,818
+177
+2% +$3.58K ﹤0.01% 2122
2019
Q2
$235K Sell
10,641
-7
-0.1% -$155 ﹤0.01% 2116
2019
Q1
$145K Buy
+10,648
New +$145K ﹤0.01% 2142
2018
Q2
Sell
-10,410
Closed -$115K 2277
2018
Q1
$115K Buy
+10,410
New +$115K ﹤0.01% 2149
2017
Q3
Sell
-140,390
Closed -$2.02M 2210
2017
Q2
$2.02M Buy
140,390
+1,950
+1% +$28K ﹤0.01% 1740
2017
Q1
$2.93M Buy
+138,440
New +$2.93M ﹤0.01% 1675